AlphaCrest Capital Management’s Chemours CC Stock Holding History

AlphaCrest Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-88,478	Closed	-$2.18M	–	193
2022 Q3	$2.18M	Buy	88,478 +56,109	+173%	+$1.85M	0.13%	206
2022 Q2	$1.04M	Buy	+32,369	New	+$1.19M	0.05%	644
2022 Q1	–	Sell	-55,513	Closed	-$1.86M	–	1260
2021 Q4	$1.86M	Sell	55,513 -7,610	-12%	-$237K	0.07%	465
2021 Q3	$1.83M	Buy	63,123 +50,054	+383%	+$1.62M	0.09%	347
2021 Q2	$455K	Buy	+13,069	New	+$433K	0.02%	981
2021 Q1	–	Sell	-9,296	Closed	-$230K	–	1192
2020 Q4	$230K	Buy	+9,296	New	+$221K	0.02%	1019
2020 Q2	–	Sell	-32,069	Closed	-$284K	–	926
2020 Q1	$284K	Buy	+32,069	New	+$462K	0.03%	819

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AlphaCrest Capital Management's CC Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Chemours (CC) in Q4 2022, closing a stake of 88,478 shares — an estimated $2.18M sold.

AlphaCrest Capital Management first reported a position in CC in Q1 2020 and held it in 7 quarters. The position peaked at $2.18M in Q3 2022. 474 funds tracked by Wall St. Rank hold CC as of Q4 2022.

AlphaCrest Capital Management reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 88,478 Chemours shares in Q4 2022, an estimated $2.18M.
AlphaCrest Capital Management first reported a position in Chemours in Q1 2020 and held it in 7 quarters.
AlphaCrest Capital Management's Chemours position peaked at $2.18M in Q3 2022.
474 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.